RAFA
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
4.17M
SBFM
Price
$1.52
Change
-$0.04 (-2.56%)
Updated
Sep 25 closing price
Capitalization
6.93M
46 days until earnings call
Interact to see
Advertisement

RAFA vs SBFM

Header iconRAFA vs SBFM Comparison
Open Charts RAFA vs SBFMBanner chart's image
Rafarma Pharmaceuticals, Inc. (WY)
Price$0.05
Change-$0.00 (-0.00%)
Volume$60.13K
Capitalization4.17M
Sunshine Biopharma
Price$1.52
Change-$0.04 (-2.56%)
Volume$72.88K
Capitalization6.93M
RAFA vs SBFM Comparison Chart in %
Loading...
RAFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RAFA vs. SBFM commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RAFA is a Hold and SBFM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (RAFA: $0.05 vs. SBFM: $1.52)
Brand notoriety: RAFA and SBFM are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: RAFA: 163% vs. SBFM: 143%
Market capitalization -- RAFA: $4.17M vs. SBFM: $6.93M
RAFA [@Pharmaceuticals: Generic] is valued at $4.17M. SBFM’s [@Pharmaceuticals: Generic] market capitalization is $6.93M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RAFA’s FA Score shows that 2 FA rating(s) are green whileSBFM’s FA Score has 0 green FA rating(s).

  • RAFA’s FA Score: 2 green, 3 red.
  • SBFM’s FA Score: 0 green, 5 red.
According to our system of comparison, RAFA is a better buy in the long-term than SBFM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RAFA’s TA Score shows that 3 TA indicator(s) are bullish while SBFM’s TA Score has 5 bullish TA indicator(s).

  • RAFA’s TA Score: 3 bullish, 6 bearish.
  • SBFM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SBFM is a better buy in the short-term than RAFA.

Price Growth

RAFA (@Pharmaceuticals: Generic) experienced а -15.73% price change this week, while SBFM (@Pharmaceuticals: Generic) price change was +3.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.72%. For the same industry, the average monthly price growth was +25.22%, and the average quarterly price growth was +68.33%.

Reported Earning Dates

SBFM is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.72% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBFM($6.93M) has a higher market cap than RAFA($4.17M). RAFA YTD gains are higher at: -38.485 vs. SBFM (-49.333).
RAFASBFMRAFA / SBFM
Capitalization4.17M6.93M60%
EBITDAN/A-6.19M-
Gain YTD-38.485-49.33378%
P/E RatioN/A0.00-
RevenueN/A36.3M-
Total CashN/A10.3M-
Total DebtN/A929K-
FUNDAMENTALS RATINGS
RAFA vs SBFM: Fundamental Ratings
RAFA
SBFM
OUTLOOK RATING
1..100
6016
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
396
PRICE GROWTH RATING
1..100
6561
P/E GROWTH RATING
1..100
284
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBFM's Valuation (40) in the null industry is in the same range as RAFA (71). This means that SBFM’s stock grew similarly to RAFA’s over the last 12 months.

SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as RAFA (100). This means that SBFM’s stock grew similarly to RAFA’s over the last 12 months.

RAFA's SMR Rating (3) in the null industry is significantly better than the same rating for SBFM (96). This means that RAFA’s stock grew significantly faster than SBFM’s over the last 12 months.

SBFM's Price Growth Rating (61) in the null industry is in the same range as RAFA (65). This means that SBFM’s stock grew similarly to RAFA’s over the last 12 months.

RAFA's P/E Growth Rating (2) in the null industry is significantly better than the same rating for SBFM (84). This means that RAFA’s stock grew significantly faster than SBFM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RAFASBFM
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 16 days ago
75%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RAFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATER1.050.01
+0.96%
Aterian
STNG57.69-0.39
-0.67%
Scorpio Tankers
EGBN21.07-0.25
-1.17%
Eagle Bancorp
GPN84.90-2.21
-2.54%
Global Payments
PNBK1.32-0.05
-3.65%
Patriot National Bancorp

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and ELAN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-2.56%
ELAN - SBFM
28%
Poorly correlated
+0.91%
TLRY - SBFM
27%
Poorly correlated
-5.56%
LFCR - SBFM
25%
Poorly correlated
-3.47%
CGC - SBFM
25%
Poorly correlated
-3.52%
ACB - SBFM
24%
Poorly correlated
-4.44%
More